Aziridine.
D000818:Animals; D001388:Aziridines / Q000494:pharmacology / Q000633:toxicity*; D001389:Azirines / Q000633:toxicity*; D002273:Carcinogens; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced; D004331:Drosophila melanogaster; D004353:Drug Evaluation, Preclinical; D005260:Female; D005804:Genes, Lethal; D005808:Genes, Recessive; D006168:Guinea Pigs; D006801:Humans; D007248:Infertility, Male / Q000139:chemically induced; D007774:Lactation / Q000187:drug effects; D007928:Lethal Dose 50; D008113:Liver Neoplasms / Q000139:chemically induced; D008175:Lung Neoplasms / Q000139:chemically induced; D008223:Lymphoma / Q000139:chemically induced; D008297:Male; D008452:Maximum Allowable Concentration; D051379:Mice; D009154:Mutation; D009492:Neurospora crassa / Q000187:drug effects; D011247:Pregnancy; D051381:Rats; D012509:Sarcoma / Q000139:chemically induced; D012878:Skin Neoplasms / Q000139:chemically induced; D014178:Translocation, Genetic
D001388:Aziridines; D001389:Azirines; D002273:Carcinogens